We compared the presentation features of three series of patients with multiple myeloma
diagnosed between 1960 and 1971 (Kyle R, Mayo Clin Proc, 1975, 50, 29, n = 869), 1972 and …

One of the priorities of personalized medicine regards the role of early integration of palliative
care with cancer-directed treatments, called simultaneous care. This article, written by the …

OBJECTIVES: In 2005, the National Health Service recommended a population-based
colorectal cancer (CRC) screening program using biennial fecal occult blood testing (FOBT), …

Bromodeoxyuridine (BUDR) is a thymidine analog which is incorporated into the DNA of
proliferating cells. Since the dose of BUDR needed to label cells is not toxic, cell labelling can …

Background The fast growing demand and the shortage of resources are pushing toward
more efficient models of survivorship care delivery. The Associazione Italiana di Oncologia …

In 16 patients with monoclonal gammopathies of undetermined significance (MGUS) and in
49 with multiple myeloma (MM, 43 untreated and 6 relapsed) we used immunocytochemistry …

The influence on survival of 21 basic clinical and hematologic parameters was evaluated in
72 patients with previously untreated myelodysplastic syndromes (MDS). Only five …

Ploidy and proliferative characteristics were estimated by flow cytometry of the nuclear DNA
content of 92 human brain tumors. Samples were frozen at ––20C immediately after surgery …

DNA flow cytometric analysis of unfixed bone marrow cells stained with propidium iodide was
carried out in 33 patients with untreated primary myelodysplastic syndromes. Patients with …

Between January 1986 and March 1990, the serum levels of thymidine kinase (TK) were
evaluated at diagnosis in 97 patients with monoclonal gammopathy of undetermined …